Life-course effects of childhood NS |
Registries of childhood onset nephrotic syndrome |
Are there risks of SSNS after 30 years? Are patients with childhood onset NS at higher risk of hypertension, CKD, and ESRD? |
cNEPTUNE (pediatric cohort of incident nephrotic syndrome patients) |
Genetic factors and biomarkers |
Multicenter collaborative cohorts of pediatric onset NS |
Can permeability factors or other biomarkers enable personalized approach to treatment? |
Can screening for genetic mutations or APOL1 variants in childhood onset NS stratify those children at highest risk for hypertension and renal disease in adulthood? |
Psychosocial impact and patient-reported outcomes |
Multicenter collaborative cohorts of pediatric onset NS |
Quality of life is significantly affected in childhood onset NS, particularly with severe disease. What is the effect on patient-reported outcomes? What is the long-term effect on educational status, employment and marital/stable relationships and are there interventions to improve outcomes? |
Transition into adulthood |
Registries and multicenter collaborative cohorts of pediatric onset NS |
(1) When should children with NS receive counseling about potential risks in adulthood? |
(2) How will adult providers be made aware of potential for complications in adults with a history of childhood NS? |
(3) Are screenings for artherosclerosis, osteoporosis, cataracts, infertility, and/or malignancy indicated? |
(4) What is the optimal transition plan for children with SSNS as they enter adulthood? |